Alterity Therapeutics Ltd Cash Flow Reinvestment Rate
Latest as of September 2023:
0.01x
Alterity Therapeutics Ltd cash flow reinvestment rate. Alterity Therapeutics Ltd (ATHE) has a Cash Flow Reinvestment Rate of 0.01x as of September 2023, reinvesting $8.00K (capex $4.00K plus investments $-4.00K) from operating cash flow of $549.00K. Explore Alterity Therapeutics Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.01x
(Capex + Investments) / Operating CF
Total Reinvested
$8.00K
Capex + Investments
Operating Cash Flow
$549.00K
USD
Capital Expenditures
$4.00K
USD
Alterity Therapeutics Ltd Cash Flow Reinvestment Rate by Year (None–None)
Alterity Therapeutics Ltd cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Alterity Therapeutics Ltd. For the full cash flow conversion analysis, see Alterity Therapeutics Ltd operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow